Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

703
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
703
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

841
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
841
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

566
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
566
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution of Infralesional Lower Motor Neuron Injury in Traumatic Cervical Spinal Cord Injury Candidates for Upper Limb Reconstruction: A Single Center Experience.

Muscle & nerve·2026
Same author

Therapy-specific motoneuron activation with epidural and dorsal root ganglion stimulation in spinal cord injury.

Journal of neurophysiology·2026
Same author

Perilesional neuromodulation replaces lost sensorimotor function in persons with spinal cord injury.

Nature biomedical engineering·2026
Same author

Increased symptomatic autonomic dysfunction is associated with greater cardiovascular endothelial dysfunction following spinal cord injury.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

Predictors of wrist extensor muscle recovery following acute traumatic spinal cord injury: A model systems replication study.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

Correlating autonomic physiology with symptoms of autonomic dysreflexia after spinal cord injury.

PM & R : the journal of injury, function, and rehabilitation·2025

Related Experiment Video

Updated: Jul 20, 2025

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K

Autonomic dysreflexia: Current pharmacologic management.

Ryan Solinsky1,2,3

  • 1Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA.

PM & R : the Journal of Injury, Function, and Rehabilitation
|August 7, 2023
PubMed
Summary
This summary is machine-generated.

Autonomic dysreflexia (AD) management for spinal cord injury (SCI) patients varies significantly. U.S. physicians favor nitroglycerin ointment, while other regions use different first-line treatments due to availability issues.

More Related Videos

A Radio-telemetric System to Monitor Cardiovascular Function in Rats with Spinal Cord Transection and Embryonic Neural Stem Cell Grafts
07:59

A Radio-telemetric System to Monitor Cardiovascular Function in Rats with Spinal Cord Transection and Embryonic Neural Stem Cell Grafts

Published on: October 7, 2014

10.6K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.3K

Related Experiment Videos

Last Updated: Jul 20, 2025

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K
A Radio-telemetric System to Monitor Cardiovascular Function in Rats with Spinal Cord Transection and Embryonic Neural Stem Cell Grafts
07:59

A Radio-telemetric System to Monitor Cardiovascular Function in Rats with Spinal Cord Transection and Embryonic Neural Stem Cell Grafts

Published on: October 7, 2014

10.6K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.3K

Area of Science:

  • Neurology
  • Pharmacology
  • Spinal Cord Injury Medicine

Background:

  • Autonomic dysreflexia (AD) is a common and potentially dangerous complication following spinal cord injury (SCI).
  • Current clinical practices and national variations in the pharmacological management of AD are not well-documented.
  • Understanding these patterns is crucial for optimizing patient care and developing standardized treatment guidelines.

Purpose of the Study:

  • To investigate current physician practices in the pharmacologic management of AD across the Americas.
  • To identify trends in medication use, protocol implementation, and factors influencing treatment decisions.
  • To highlight potential national differences in AD pharmacotherapy.

Main Methods:

  • An international survey was conducted among physicians specializing in SCI care.
  • Sixty physicians who manage SCI patients and prescribe AD medications participated.
  • Data collected included the presence of formal AD management protocols, first- and second-line medications, and patient characteristics influencing treatment choices.

Main Results:

  • A majority of physicians (69%) reported having a formal inpatient AD management protocol.
  • Nitroglycerin ointment was the most common first-line medication (82%), particularly among U.S. physicians (98%).
  • Significant national disparities were observed; Canadian and Latin American physicians did not use nitroglycerin ointment due to availability issues, leading to different first-line choices. Hydralazine (48%) and nifedipine (28%) were common second-line options. Treatment decisions were influenced by systolic blood pressure thresholds (56%) and neurological level of injury (26%), but rarely by heart rate (5%).

Conclusions:

  • As of 2023, U.S. physicians predominantly utilize formal inpatient protocols for AD management, with widespread use of nitroglycerin ointment as the primary treatment.
  • Pharmacological practice patterns for AD differ substantially in regions outside the U.S. where nitroglycerin ointment is unavailable.
  • These findings underscore the need for regionalized treatment strategies and improved medication accessibility for AD management in SCI patients.